Immune cell activation mediated by polysaccharides and saponins

Immune cell activation mediated by polysaccharides and saponins refers to a complex pharmacological mechanism rather than a single molecular target. This process involves the stimulation of various innate and adaptive immune cells, such as dendritic cells, macrophages, and T-lymphocytes, through the interaction of specific natural compounds with cellular receptors and membranes. Polysaccharides, including beta-glucans and mannans, primarily act as ligands for pattern recognition receptors like Dectin-1, triggering signaling cascades that promote pro-inflammatory cytokine release and phagocytosis (Goodridge et al., Nature, 2009). Saponins, particularly the triterpene glycoside QS-21, are potent adjuvants that enhance the magnitude and quality of the immune response by promoting antigen cross-presentation and activating the NLRP3 inflammasome (Lacaille-Dubois, Phytomedicine, 2019). These mechanisms are extensively utilized in vaccine development, such as in the AS01 adjuvant system used in Shingrix, to elicit robust cellular and humoral immunity against infectious agents and cancer antigens. Because this term describes a multi-receptor biological pathway and a class of adjuvant effects, it is classified as a mechanism of action rather than a discrete protein target.

Other names

Polysaccharide-mediated immunomodulationSaponin-based adjuvancyAdjuvant-induced immune activationCarbohydrate-mediated immune stimulation

Polysaccharides typically function as agonists for pattern recognition receptors (PRRs) such as Dectin-1, Toll-like receptor 2 (TLR2), and TLR4, leading to the maturation of antigen-presenting cells. Saponins, such as QS-21, are believed to act by inducing local cytokine production, facilitating the endosomal escape of antigens to enhance cross-presentation to CD8+ T-cells, and activating the NLRP3 inflammasome.